Details for Patent: 8,642,556
✉ Email this page to a colleague
Which drugs does patent 8,642,556 protect, and when does it expire?
Patent 8,642,556 protects RESTASIS MULTIDOSE and is included in one NDA.
This patent has one patent family member in one country.
Summary for Patent: 8,642,556
Title: | Methods of providing therapeutic effects using cyclosporin components |
Abstract: | Methods of treating an eye of a human or animal include administering to an eye of a human or animal a composition in the form of an emulsion including water, a hydrophobic component and a cyclosporin component in a therapeutically effective amount of less than 0.1% by weight of the composition. The weight ratio of the cyclosporin component to the hydrophobic component is less than 0.8. |
Inventor(s): | Acheampong; Andrew (Irvine, CA), Tang-Liu; Diane D. (Las Vegas, NV), Chang; James N. (Newport Beach, CA), Power; David F. (Hubert, NC) |
Assignee: | Allergan, Inc. (Irvine, CA) |
Application Number: | 13/967,189 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,642,556 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,642,556
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Abbvie | RESTASIS MULTIDOSE | cyclosporine | EMULSION;OPHTHALMIC | 050790-002 | Oct 27, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,642,556
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
World Intellectual Property Organization (WIPO) | 2005032577 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |